Philips sues Boston Scientific over cardiac diagnostic patents
03-11-2020
Lab instrument maker accuses rival of stealing trade secrets
02-11-2020
Pavel Kapysh / Shutterstock.com
The US Court of Appeals for the Federal Circuit has cancelled a lower court ruling holding that a Bard patent for a vascular access device was both not infringed and patent-ineligible.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Bard, Federal Circuit, AngioDynamics, vascular access port, Delaware, district court, patent, infringement
